circulating non coding rnas diagnostic (21 Ergebnisse)

Zustand: New.

Hardcover. Zustand: new. Hardcover. This Reprint of the IJMS Special Issue "Circulating Non-Coding RNAs as Diagnostic and Prognostic Markers of Human Diseases" presents eight original research papers and five reviews that advance our diagnostic, prognostic, and mechanistic understanding of circulating non-coding RNAs (c-ncRNAs). The collection emphasizes the remarkable stability of c-ncRNAs in biofluids such as blood and urine, their tissue- and disease-specific expression profiles, and their growing promise in non-invasive liquid biopsy for precision medicine, spanning early detection, risk assessment, and therapeutic monitoring. Featured studies explore early lung cancer prediction in COPD via miR-206 and miR-1246; risk stratification in atrial fibrillation using miR-411-5p; the differentiation of coronary artery aneurysmal disease through miR-451a and miR-328-3p; the staging of mycosis fungoides by plasma miR-146a and miR-155; and asthma phenotyping associated with hsa-miR-26a-1-3p and hsa-miR-376a-3p. Additional research investigates NAFLD diagnostics using serum miRNA ratios and provides mechanistic insight into muscle development via circTTN. The reviews synthesize advances on c-miRNAs in osteoarthritis, miRNA and exosomal miRNA dysregulation in cholesteatoma, therapeutic biomarkers in asthma, and post-SARS-CoV-2 cardiovascular alterations, highlighting broad clinical relevance across oncologic, cardiovascular, metabolic, and inflammatory disorders. Collectively, these contributions underscore methodological progress toward standardization and position c-ncRNAs at the forefront of minimally invasive diagnostics and personalized therapy. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

HRD. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

HRD. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Hardcover. Zustand: new. Hardcover. This Reprint presents a curated collection of twelve peer-reviewed articles, comprising nine original research papers and three reviews, that examine the diagnostic, prognostic, and therapeutic potential of circulating non-coding RNAs (ncRNAs) across a wide range of human diseases. The contributions cover multiple disciplines, including oncology, neurology, psychiatry, immunology, and reproductive health, showcasing the versatility of ncRNAs-such as microRNAs, long non-coding RNAs, and circular RNAs-as biomarkers detectable in blood and other biofluids. This Reprint highlights recent progress in the discovery, validation, and mechanistic characterization of ncRNAs, emphasizing their value in disease stratification, the prediction of treatment response, and longitudinal monitoring. Within this Reprint, the potential of multi-analyte biopsy approaches is also highlighted, underscoring how ncRNAs can be combined with other circulating biomarkers, such as cell-free DNA, proteins, and extracellular vesicles, to advance precision medicine. Together, these contributions reflect the growing momentum of research regarding ncRNA and its translation into clinical applications. This Reprint provides a timely resource for researchers, clinicians, and industry professionals interested in leveraging non-coding RNAs to develop minimally invasive diagnostics and personalized therapeutic strategies. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

HRD. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

HRD. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Zustand: New. Print on Demand.

Zustand: New. Print on Demand.

Zustand: New. PRINT ON DEMAND.

Hardcover. Zustand: new. Hardcover. This Reprint of the IJMS Special Issue "Circulating Non-Coding RNAs as Diagnostic and Prognostic Markers of Human Diseases" presents eight original research papers and five reviews that advance our diagnostic, prognostic, and mechanistic understanding of circulating non-coding RNAs (c-ncRNAs). The collection emphasizes the remarkable stability of c-ncRNAs in biofluids such as blood and urine, their tissue- and disease-specific expression profiles, and their growing promise in non-invasive liquid biopsy for precision medicine, spanning early detection, risk assessment, and therapeutic monitoring. Featured studies explore early lung cancer prediction in COPD via miR-206 and miR-1246; risk stratification in atrial fibrillation using miR-411-5p; the differentiation of coronary artery aneurysmal disease through miR-451a and miR-328-3p; the staging of mycosis fungoides by plasma miR-146a and miR-155; and asthma phenotyping associated with hsa-miR-26a-1-3p and hsa-miR-376a-3p. Additional research investigates NAFLD diagnostics using serum miRNA ratios and provides mechanistic insight into muscle development via circTTN. The reviews synthesize advances on c-miRNAs in osteoarthritis, miRNA and exosomal miRNA dysregulation in cholesteatoma, therapeutic biomarkers in asthma, and post-SARS-CoV-2 cardiovascular alterations, highlighting broad clinical relevance across oncologic, cardiovascular, metabolic, and inflammatory disorders. Collectively, these contributions underscore methodological progress toward standardization and position c-ncRNAs at the forefront of minimally invasive diagnostics and personalized therapy. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

Zustand: New. Print on Demand.

Zustand: New. Print on Demand.

Zustand: New. PRINT ON DEMAND.

Hardcover. Zustand: new. Hardcover. This Reprint of the IJMS Special Issue "Circulating Non-Coding RNAs as Diagnostic and Prognostic Markers of Human Diseases" presents eight original research papers and five reviews that advance our diagnostic, prognostic, and mechanistic understanding of circulating non-coding RNAs (c-ncRNAs). The collection emphasizes the remarkable stability of c-ncRNAs in biofluids such as blood and urine, their tissue- and disease-specific expression profiles, and their growing promise in non-invasive liquid biopsy for precision medicine, spanning early detection, risk assessment, and therapeutic monitoring. Featured studies explore early lung cancer prediction in COPD via miR-206 and miR-1246; risk stratification in atrial fibrillation using miR-411-5p; the differentiation of coronary artery aneurysmal disease through miR-451a and miR-328-3p; the staging of mycosis fungoides by plasma miR-146a and miR-155; and asthma phenotyping associated with hsa-miR-26a-1-3p and hsa-miR-376a-3p. Additional research investigates NAFLD diagnostics using serum miRNA ratios and provides mechanistic insight into muscle development via circTTN. The reviews synthesize advances on c-miRNAs in osteoarthritis, miRNA and exosomal miRNA dysregulation in cholesteatoma, therapeutic biomarkers in asthma, and post-SARS-CoV-2 cardiovascular alterations, highlighting broad clinical relevance across oncologic, cardiovascular, metabolic, and inflammatory disorders. Collectively, these contributions underscore methodological progress toward standardization and position c-ncRNAs at the forefront of minimally invasive diagnostics and personalized therapy. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Hardcover. Zustand: new. Hardcover. This Reprint presents a curated collection of twelve peer-reviewed articles, comprising nine original research papers and three reviews, that examine the diagnostic, prognostic, and therapeutic potential of circulating non-coding RNAs (ncRNAs) across a wide range of human diseases. The contributions cover multiple disciplines, including oncology, neurology, psychiatry, immunology, and reproductive health, showcasing the versatility of ncRNAs-such as microRNAs, long non-coding RNAs, and circular RNAs-as biomarkers detectable in blood and other biofluids. This Reprint highlights recent progress in the discovery, validation, and mechanistic characterization of ncRNAs, emphasizing their value in disease stratification, the prediction of treatment response, and longitudinal monitoring. Within this Reprint, the potential of multi-analyte biopsy approaches is also highlighted, underscoring how ncRNAs can be combined with other circulating biomarkers, such as cell-free DNA, proteins, and extracellular vesicles, to advance precision medicine. Together, these contributions reflect the growing momentum of research regarding ncRNA and its translation into clinical applications. This Reprint provides a timely resource for researchers, clinicians, and industry professionals interested in leveraging non-coding RNAs to develop minimally invasive diagnostics and personalized therapeutic strategies. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

Hardcover. Zustand: new. Hardcover. This Reprint presents a curated collection of twelve peer-reviewed articles, comprising nine original research papers and three reviews, that examine the diagnostic, prognostic, and therapeutic potential of circulating non-coding RNAs (ncRNAs) across a wide range of human diseases. The contributions cover multiple disciplines, including oncology, neurology, psychiatry, immunology, and reproductive health, showcasing the versatility of ncRNAs-such as microRNAs, long non-coding RNAs, and circular RNAs-as biomarkers detectable in blood and other biofluids. This Reprint highlights recent progress in the discovery, validation, and mechanistic characterization of ncRNAs, emphasizing their value in disease stratification, the prediction of treatment response, and longitudinal monitoring. Within this Reprint, the potential of multi-analyte biopsy approaches is also highlighted, underscoring how ncRNAs can be combined with other circulating biomarkers, such as cell-free DNA, proteins, and extracellular vesicles, to advance precision medicine. Together, these contributions reflect the growing momentum of research regarding ncRNA and its translation into clinical applications. This Reprint provides a timely resource for researchers, clinicians, and industry professionals interested in leveraging non-coding RNAs to develop minimally invasive diagnostics and personalized therapeutic strategies. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This Reprint of the IJMS Special Issue 'Circulating Non-Coding RNAs as Diagnostic and Prognostic Markers of Human Diseases' presents eight original research papers and five reviews that advance our diagnostic, prognostic, and mechanistic understanding of circulating non-coding RNAs (c-ncRNAs). The collection emphasizes the remarkable stability of c-ncRNAs in biofluids such as blood and urine, their tissue- and disease-specific expression profiles, and their growing promise in non-invasive liquid biopsy for precision medicine, spanning early detection, risk assessment, and therapeutic monitoring. Featured studies explore early lung cancer prediction in COPD via miR-206 and miR-1246; risk stratification in atrial fibrillation using miR-411-5p; the differentiation of coronary artery aneurysmal disease through miR-451a and miR-328-3p; the staging of mycosis fungoides by plasma miR-146a and miR-155; and asthma phenotyping associated with hsa-miR-26a-1-3p and hsa-miR-376a-3p. Additional research investigates NAFLD diagnostics using serum miRNA ratios and provides mechanistic insight into muscle development via circTTN. The reviews synthesize advances on c-miRNAs in osteoarthritis, miRNA and exosomal miRNA dysregulation in cholesteatoma, therapeutic biomarkers in asthma, and post-SARS-CoV-2 cardiovascular alterations, highlighting broad clinical relevance across oncologic, cardiovascular, metabolic, and inflammatory disorders. Collectively, these contributions underscore methodological progress toward standardization and position c-ncRNAs at the forefront of minimally invasive diagnostics and personalized therapy.

Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This Reprint presents a curated collection of twelve peer-reviewed articles, comprising nine original research papers and three reviews, that examine the diagnostic, prognostic, and therapeutic potential of circulating non-coding RNAs (ncRNAs) across a wide range of human diseases. The contributions cover multiple disciplines, including oncology, neurology, psychiatry, immunology, and reproductive health, showcasing the versatility of ncRNAs-such as microRNAs, long non-coding RNAs, and circular RNAs-as biomarkers detectable in blood and other biofluids. This Reprint highlights recent progress in the discovery, validation, and mechanistic characterization of ncRNAs, emphasizing their value in disease stratification, the prediction of treatment response, and longitudinal monitoring. Within this Reprint, the potential of multi-analyte biopsy approaches is also highlighted, underscoring how ncRNAs can be combined with other circulating biomarkers, such as cell-free DNA, proteins, and extracellular vesicles, to advance precision medicine. Together, these contributions reflect the growing momentum of research regarding ncRNA and its translation into clinical applications. This Reprint provides a timely resource for researchers, clinicians, and industry professionals interested in leveraging non-coding RNAs to develop minimally invasive diagnostics and personalized therapeutic strategies.

Buch. Zustand: Neu. Circulating Non-coding RNAs as Diagnostic and Prognostic Markers of Human Diseases | Buch | Englisch | 2025 | MDPI AG | EAN 9783725856671 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.

Buch. Zustand: Neu. Circulating Non-coding RNAs as Diagnostic and Prognostic Markers of Human Diseases | 2nd Edition | Buch | Englisch | 2025 | MDPI AG | EAN 9783725856695 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.